Human CD151 Protein, Flag,His Tag (Detergent)
分子別名（Synonym）
EBS7, GP27, MER2, PETA-3, RAPH, SFA1, TSPAN24
表達區(qū)間及表達系統(tǒng)（Source）
Human CD151 Protein, Flag,His Tag (CD1-H52D3) is expressed from human 293 cells (HEK293). It contains AA Gly 2 - Tyr 253 (Accession # P48509).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)（Molecular Characterization）
This protein carries flag tag at the N-terminus and polyhistidine tag at the C-terminus.
The protein has a calculated MW of 32.2 kDa.
內(nèi)毒素（Endotoxin）
Less than 1.0 EU per μg by the LAL method.
制劑（Formulation）
This product is not suitable for cell based experiments due to cytotoxicity of DDM.
DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumastance should you remove DDM and CHS.
DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
If glycerol is not compatible to your application, remove glycerol just before immediate experiment, and NEVER store glycerol-free protein solution.
Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM NaCl, DDM, CHS, pH7.5 with glycerol as protectant.
Contact us for customized product form or formulation.
運輸（Shipping）
This product is supplied and shipped with dry ice, please inquire the shipping cost.
存儲（Storage）
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
The product MUST be stored at -70°C or lower upon receipt;
-70°C for 3 months under sterile conditions.
背景（Background）
該基因編碼的蛋白質(zhì)是跨膜4超家族的成員，也稱為tetraspanin家族。這些成員中的大多數(shù)是細胞表面蛋白，其特征是存在四個疏水結(jié)構(gòu)域。這些蛋白質(zhì)介導(dǎo)信號轉(zhuǎn)導(dǎo)事件，在細胞發(fā)育、活化、生長和運動的調(diào)節(jié)中發(fā)揮作用。這種編碼的蛋白質(zhì)是一種細胞表面糖蛋白，已知與整合素和其他跨膜4超家族蛋白復(fù)合。它參與細胞過程，包括細胞粘附，并可能調(diào)節(jié)整合素的運輸和/或功能。該蛋白增強癌癥細胞的運動、侵襲和轉(zhuǎn)移。編碼相同蛋白質(zhì)的多個選擇性剪接轉(zhuǎn)錄物變體已被描述用于該基因。
關(guān)鍵字： CD151;CD151蛋白;CD151重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。